ORABODY
LIVE

Serial Number

87150012

Owner

Landing Biotech, Inc.

First Use Date

Dec 28, 2015

Filing Date

Aug 24, 2016

Add to watchlist:

No watchlists yet
View on USPTO

ORABODY Trademark

Serial Number: 87150012 • Registration: 5336498

ORABODY is a trademark filed by Landing Biotech, Inc. on August 24, 2016. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

Landing Biotech, Inc. (2 trademarks)

Vacaville, CA 95688

Entity Type: 03

Trademark Details

Filing Date

August 24, 2016

Registration Date

November 14, 2017

First Use Anywhere

December 28, 2015

First Use in Commerce

August 1, 2016

Published for Opposition

January 10, 2017

Goods & Services

Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of powders that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, for the treatment of bacteria-based diseases, and for the treatment of diabetes, and anti - infective preparations, antiviral preparations, antibiotics, antifungal preparations and vaccines; Pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; Pharmaceutical products for the prevention and treatment of cancer

Filing History

NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
Nov 15, 2023 NAS8
REGISTERED - SEC. 8 (6-YR) ACCEPTED
Nov 15, 2023 8.OK
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
Nov 9, 2023 EROP
OFFICE ACTION ISSUED POU1
Nov 21, 2022 PUM1
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Nov 20, 2022 APRE
TEAS SECTION 8 RECEIVED
Nov 15, 2022 ES8R
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Nov 14, 2022 REM1
REGISTERED-PRINCIPAL REGISTER
Nov 14, 2017 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Oct 12, 2017 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Oct 11, 2017 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Sep 18, 2017 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Sep 18, 2017 AITU
USE AMENDMENT FILED
Sep 1, 2017 IUAF
TEAS STATEMENT OF USE RECEIVED
Sep 1, 2017 EISU
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Mar 8, 2017 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 10, 2017 NPUB
PUBLISHED FOR OPPOSITION
Jan 10, 2017 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 21, 2016 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 4, 2016 CNSA
ASSIGNED TO EXAMINER
Dec 4, 2016 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 30, 2016 NWOS
NEW APPLICATION ENTERED
Aug 27, 2016 NWAP